ENQUIRE NOW

u300951854_demo

  • Home
  • Author: u300951854_demo

u300951854_demo

How Membrane Selection Affects IVPT Outcomes in Topical Drug Development
17
Jun
By No Comments

How Membrane Selection Affects IVPT Outcomes in Topical Drug Development

In Vitro Permeation Testing (IVPT) has become an essential tool in the development and evaluation of topical and transdermal drug products. By measuring the movement of an active pharmaceutical ingredient (API) across a membrane over time, IVPT helps scientists assess drug delivery performance, compare formulations, and support bioequivalence strategies. However, the reliability of IVPT data […]
Continue Reading
Pharmaceutical Polymer Synthesis for Controlled-Release Drug Delivery
26
May
By No Comments

Pharmaceutical Polymer Synthesis for Controlled-Release Drug Delivery

In controlled drug delivery, product performance depends as much on polymer behaviour as on the active ingredient itself. A drug may have the right pharmacology, but if the surrounding material system is not designed properly, the formulation may still fail to achieve its intended release profile, stability target, or therapeutic performance. This is where pharmaceutical […]
Continue Reading
How Excipient Design Shapes Stability and Drug Delivery
25
May
By No Comments

How Excipient Design Shapes Stability and Drug Delivery

In many pharmaceutical products, formulation success depends as much on excipient design as on the active ingredient itself. A drug candidate may show strong therapeutic potential yet still fail because the surrounding formulation environment is not designed to support its target quality and performance profile. This is where excipients become critically important. They do far […]
Continue Reading
Custom Excipient Synthesis for Complex Drug Formulations
12
May
By No Comments

Custom Excipient Synthesis for Complex Drug Formulations

Many promising drug candidates fail in formulation not because of weak pharmacology, but because standard excipients cannot support their development requirements. Modern pharmaceutical pipelines increasingly include molecules with poor aqueous solubility, low physical or chemical stability, limited bioavailability, incompatible processing behavior, or delivery constraints that conventional formulation systems struggle to address. In these cases, the […]
Continue Reading
Why Headspace GC-MS Matters in Volatile Impurity Analysis for Pharma Quality and Compliance
23
Apr
By No Comments

Why Headspace GC-MS Matters in Volatile Impurity Analysis for Pharma Quality and Compliance

Volatile impurities may be present in small amounts, but their impact on pharmaceutical quality can be serious. They can affect product safety, stability, odour, purity profile, and regulatory acceptability. In some cases, they may also indicate process inefficiencies, contamination risks, material compatibility issues, or incomplete solvent removal. That is why volatile impurity analysis is an […]
Continue Reading
Residual Solvent Testing by Headspace GC-MS: A Practical Guide for Pharma Teams
20
Apr
By No Comments

Residual Solvent Testing by Headspace GC-MS: A Practical Guide for Pharma Teams

Residual solvents may be present in very small amounts, but their impact on pharmaceutical quality can be significant. They can affect product safety, impurity profiles, stability, regulatory acceptability, and batch release decisions. That is why residual solvent testing by Headspace GC-MS remains a critical part of pharmaceutical analysis. For pharma teams involved in development, quality […]
Continue Reading